Showing results (131-140 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|February 9, 2017
Transforming Cancer Epigenetics Using Nutritive Approaches and Noncoding RNAsCentdrika R Dates, Trygve O TollefsbolCurrent Cancer Drug Targets|February 9, 2017
Outlook on Epigenetic Therapeutic Approaches for Treatment of Gastric CancerPetra HudlerCurrent Cancer Drug Targets|March 28, 2019
Polyisoprenylated Cysteinyl Amide Inhibitors Deplete K-Ras and Induce Caspase-dependent Apoptosis in Lung Cancer CellsAugustine T Nkembo, Felix Amissah, Elizabeth Ntantie, et al.Current Cancer Drug Targets|March 11, 2014
Biomarkers for systemic therapy in ovarian cancerZsofia Penzvalto, Pawel Surowiak, Balazs GyorffyCurrent Cancer Drug Targets|June 10, 2008
The inhibitor of growth (ING) gene family: potential role in cancer therapyMehmet Gunduz, Esra Gunduz, Rosario S Rivera, et al.Current Cancer Drug Targets|June 10, 2008
Skeletal muscle in cancer cachexia: the ideal target of drug therapyMaurizio Bossola, Fabio Pacelli, Antonio Tortorelli, et al.Current Cancer Drug Targets|June 10, 2008
Regulators of chemokine receptor activity as promising anticancer therapeuticsKonstantin V Balakin, Yan A Ivanenkov, Sergey E Tkachenko, et al.Current Cancer Drug Targets|September 12, 2019
Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan's Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced DiarrheaRongjin Sun, Sumit Basu, Min Zeng, et al.Current Cancer Drug Targets|September 13, 2019
C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular CarcinomaZhuo Xu, Shao-Hua Meng, Jian-Guo Bai, et al.Current Cancer Drug Targets|August 28, 2025
SOX9 Promotes Breast Cancer Progression via the EGFR/STAT3 Signaling AxisChunrui Zhang, Na Li, Fei Xue, et al.Pageof 187